CannX is introducing free webinar series to keep you informed and connected in the following months.
Webinar: Real-World Evidence and Medical Cannabis
Date: Oct 20, 2020 05:00 PM in Jerusalem (GMT+3:00)
The FDA defines Real-World Evidence as the “clinical evidence regarding the usage and potential benefits or risks of a medical product derived from analysis of Real-world data”. Although double-blind randomized trials have been the “holy grail” in clinical studies for decades, Real-World Evidence is increasingly playing an important role in health care decision. This development is partly facilitated by the use of computers, mobile devices and other digital platforms. Given that cannabis is being used by millions of patients worldwide, without being proven as safe and effective by randomized trials, Real-World Evidence is an invaluable tool for advising clinicians and patients alike regarding safe and effective usage of medical cannabis.
In this CannX webinar, two experts of Real-World Evidence on medical cannabis will present substantial data and discuss directions for future developments.
Moderator: Dr. Yuval Zolotov, Senior Research Associate, Regional Alcohol and Drug Abuse Research Center, Ben Gurion University of the Negev (Israel) Speakers:
- Dr. Joshua Aviram Postdoctoral Fellow, Prof. Meiri’s Laboratory of Cancer Biology and Cannabinoid Research, Faculty of Biology, Technion –Institute of Technology (Israel)
- Mr. David Berg President & Chief Technical Officer, Strainprint (Canada)
Webinar: Emerging Medical Indications for Cannabinoid-based Therapies
Date: Sep 17, 2020 05:00 PM in Jerusalem (GMT+3:00)
Cannabinoids have been traditionally used for a limited number of indications, such as multiple sclerosis and chemotherapy-induced nausea. In recent years, however, both scientific evidence and clinical experience are pointing to the potential of cannabis and cannabinoids for treating new medical indications. In this webinar, two clinicians will share their vast experience of using cannabinoids as a promising treatment option.
Dr. Yuval Zolotov, Senior Research Associate, Regional Alcohol and Drug Abuse Research Center, Ben Gurion University of the Negev (Israel)
• Dr. Vincent Maida
Associate Professor, University of Toronto & Medical Director, Hospice Vaughan (Canada)
• Dr. Addie Ron
Medical Director, Nia Medic Healthcare & Research Services (Israel)
Medical Cannabis and the Capital Market: Current Trends and Future Perspectives
Date: 19 August 2020, 4 PM CET, 10 AM EST, 45 mins
Moderator: Yael Meir, Chief Operations Officer, Cann10, Israel
Three international capital experts will discuss the current trends of the medical cannabis marketplace, as well as the challenges associated with fund raising in times of economic recession and limited international trading. They will additionally share insights about future perspectives of this market.
The Long and Bumpy Road of Turning Cannabis into Medicine
Date: 23 July 2020
• Prof. Hinanit Koltai
Institute of Plant Science, ARO, Volcani Center, Israel
• Dr. Fabricio Pamplona
Head of Science – CSO at Proprium Health Technology and Science, Brazil